SGMT
Price
$3.40
Change
-$0.15 (-4.24%)
Updated
Mar 11 closing price
Capitalization
109.3M
19 days until earnings call
XNCR
Price
$13.45
Change
-$0.18 (-1.32%)
Updated
Mar 11 closing price
Capitalization
947.71M
57 days until earnings call
Ad is loading...

SGMT vs XNCR

Header iconSGMT vs XNCR Comparison
Open Charts SGMT vs XNCRBanner chart's image
Sagimet Biosciences
Price$3.40
Change-$0.15 (-4.24%)
Volume$360.04K
Capitalization109.3M
Xencor
Price$13.45
Change-$0.18 (-1.32%)
Volume$577.44K
Capitalization947.71M
SGMT vs XNCR Comparison Chart
Loading...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SGMT vs. XNCR commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGMT is a Hold and XNCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (SGMT: $3.54 vs. XNCR: $13.63)
Brand notoriety: SGMT and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SGMT: 47% vs. XNCR: 125%
Market capitalization -- SGMT: $109.3M vs. XNCR: $947.71M
SGMT [@Biotechnology] is valued at $109.3M. XNCR’s [@Biotechnology] market capitalization is $947.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGMT’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • SGMT’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both SGMT and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGMT’s TA Score shows that 2 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • SGMT’s TA Score: 2 bullish, 4 bearish.
  • XNCR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than SGMT.

Price Growth

SGMT (@Biotechnology) experienced а +2.61% price change this week, while XNCR (@Biotechnology) price change was -5.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.61%. For the same industry, the average monthly price growth was -8.15%, and the average quarterly price growth was -7.40%.

Reported Earning Dates

SGMT is expected to report earnings on May 14, 2025.

XNCR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+0.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($948M) has a higher market cap than SGMT($109M). SGMT YTD gains are higher at: -24.556 vs. XNCR (-41.471). SGMT has higher annual earnings (EBITDA): -45.73M vs. XNCR (-198.91M). XNCR has more cash in the bank: 543M vs. SGMT (152M). SGMT has less debt than XNCR: SGMT (116K) vs XNCR (86.6M). XNCR has higher revenues than SGMT: XNCR (85.2M) vs SGMT (0).
SGMTXNCRSGMT / XNCR
Capitalization109M948M11%
EBITDA-45.73M-198.91M23%
Gain YTD-24.556-41.47159%
P/E RatioN/AN/A-
Revenue085.2M-
Total Cash152M543M28%
Total Debt116K86.6M0%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SGMTXNCR
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 15 days ago
86%
Bullish Trend 13 days ago
72%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X82862.2100004330.211000
+5.51%
Bitcoin cryptocurrency
TSLA230.588.43
+3.79%
Tesla
GME22.610.19
+0.85%
GameStop Corp
SPY555.92-4.66
-0.83%
SPDR® S&P 500® ETF Trust
AAPL220.84-6.64
-2.92%
Apple

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with VRDN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
-4.10%
VRDN - SGMT
38%
Loosely correlated
+3.27%
CRBU - SGMT
36%
Loosely correlated
-3.17%
XNCR - SGMT
36%
Loosely correlated
-1.32%
FATE - SGMT
35%
Loosely correlated
+3.57%
NWPHF - SGMT
35%
Loosely correlated
N/A
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with ERAS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-1.32%
ERAS - XNCR
48%
Loosely correlated
+7.69%
RLAY - XNCR
48%
Loosely correlated
+6.12%
IMNM - XNCR
45%
Loosely correlated
-1.36%
ACLX - XNCR
45%
Loosely correlated
-5.21%
TRDA - XNCR
44%
Loosely correlated
+1.43%
More